"Crohn Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients.
| Descriptor ID |
D003424
|
| MeSH Number(s) |
C06.405.205.731.500 C06.405.469.432.500
|
| Concept/Terms |
Crohn Disease- Crohn Disease
- Crohn's Enteritis
- Regional Enteritis
- Crohn's Disease
- Crohns Disease
- Inflammatory Bowel Disease 1
Ileitis, Terminal- Ileitis, Terminal
- Terminal Ileitis
- Ileitis, Regional
- Regional Ileitides
- Regional Ileitis
|
Below are MeSH descriptors whose meaning is more general than "Crohn Disease".
Below are MeSH descriptors whose meaning is more specific than "Crohn Disease".
This graph shows the total number of publications written about "Crohn Disease" by people in this website by year, and whether "Crohn Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 4 | 1 | 5 |
| 1997 | 4 | 0 | 4 |
| 1998 | 6 | 1 | 7 |
| 1999 | 8 | 2 | 10 |
| 2000 | 15 | 1 | 16 |
| 2001 | 13 | 1 | 14 |
| 2002 | 17 | 2 | 19 |
| 2003 | 12 | 2 | 14 |
| 2004 | 23 | 0 | 23 |
| 2005 | 18 | 0 | 18 |
| 2006 | 13 | 4 | 17 |
| 2007 | 23 | 4 | 27 |
| 2008 | 12 | 3 | 15 |
| 2009 | 11 | 2 | 13 |
| 2010 | 12 | 2 | 14 |
| 2011 | 15 | 5 | 20 |
| 2012 | 14 | 3 | 17 |
| 2013 | 22 | 3 | 25 |
| 2014 | 16 | 0 | 16 |
| 2015 | 8 | 4 | 12 |
| 2016 | 20 | 3 | 23 |
| 2017 | 15 | 3 | 18 |
| 2018 | 22 | 1 | 23 |
| 2019 | 13 | 4 | 17 |
| 2020 | 22 | 3 | 25 |
| 2021 | 23 | 1 | 24 |
| 2022 | 30 | 0 | 30 |
| 2023 | 29 | 0 | 29 |
| 2024 | 17 | 7 | 24 |
| 2025 | 20 | 1 | 21 |
| 2026 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Crohn Disease" by people in Profiles.
-
Intestinal Ultrasound for Monitoring Postoperative Crohn's Disease: A Review and Visual Atlas. Inflamm Bowel Dis. 2026 Apr 01; 32(4):755-764.
-
Reliability and Validity of Mesenteric Fat Assessment by Intestinal Ultrasound in Pediatric Crohn's Disease Using the Chicago Mesenteric Fat Index. Inflamm Bowel Dis. 2026 Mar 01; 32(3):444-451.
-
The Chicago Mesenteric Fat Index: A Novel Metric for Point-of-Care Intestinal Ultrasound Evaluation of Mesenteric Fat Wrapping in Crohn's Disease. Inflamm Bowel Dis. 2026 03 01; 32(3):452-460.
-
Comparing Outcomes With Subcutaneous Infliximab (CT-P13 SC) by Baseline Immunosuppressant Use: A Post Hoc Analysis of the LIBERTY-CD and LIBERTY-UC Studies. Inflamm Bowel Dis. 2025 Oct 01; 31(10):2714-2724.
-
International consensus on the use of intestinal ultrasound in inflammatory bowel disease trials. J Crohns Colitis. 2025 Sep 28; 19(9).
-
Real-world Experience of Upadacitinib Reinduction and High-dose Maintenance Therapy in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2026 Mar; 24(3):763-771.
-
A Guide to the Patient-Centric Use of Vedolizumab for Crohn's Disease. Inflamm Bowel Dis. 2025 Aug 01; 31(8):2269-2285.
-
Impact of moderate-to-severe ulcerative colitis and Crohn's disease on sexual activity: United States and European patient perspectives from the communicating needs and features of IBD experiences (CONFIDE) survey. Curr Med Res Opin. 2025 Jun; 41(6):1017-1030.
-
Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trials. Lancet. 2025 Jul 26; 406(10501):358-375.
-
Broad Impact of Bowel Urgency in Ulcerative Colitis and Crohn's Disease: US, European, and Japanese Patient and Healthcare Professional Perspectives from the Communicating Needs and Features of IBD Experiences (CONFIDE) Survey. Adv Ther. 2025 Sep; 42(9):4510-4526.